Morphoea (Q44160): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
Grupo de doenças relacionadas, de etiologia pouco compreendida, que afetam principalmente a pele e o tecido subcutâneo e são caracterizadas por fibrose, esclerose e atrofia cutâneas variáveis.
description / endescription / en
 
A group of related diseases of poorly understood aetiology affecting principally skin and subcutaneous tissue and characterised by variable fibrosis, sclerosis and cutaneous atrophy.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/31664821 / rank
 
Normal rank
Property / CURIE
 
CID11:EB61
Property / CURIE: CID11:EB61 / rank
 
Normal rank
Property / Canary Token
 
dki-india-EB61
Property / Canary Token: dki-india-EB61 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: L94.0 / rank
 
Normal rank

Latest revision as of 11:31, 13 August 2026

A group of related diseases of poorly understood aetiology affecting principally skin and subcutaneous tissue and characterised by variable fibrosis, sclerosis and cutaneous atrophy.
Language Label Description Also known as
default for all languages
EB61
    English
    Morphoea
    A group of related diseases of poorly understood aetiology affecting principally skin and subcutaneous tissue and characterised by variable fibrosis, sclerosis and cutaneous atrophy.

      Statements

      CID11:EB61
      0 references
      dki-india-EB61
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references